Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> PFIZER Latest News

11 HOURS AGO - Benzinga

A Must Read - Share

SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely'

Pfizer Inc. (NYSE: PFE) is likely to boost its offer for British drug maker AstraZeneca PLC (NYSE: AZN) to $96.28 a share, an analyst said Tuesday.

Tags: SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC 'Highly Likely',  Pfizer Latest News

18 HOURS AGO - Yahoo! News

A Must Read - Share

Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors

By Ben Hirschler BARCELONA (Reuters) - Though speculation is rife of a new Pfizer bid, AstraZeneca's chief executive is not holed up with advisers in London or New York. Instead, he has spent the last three days immersed in heart science in Barcelona. "The only thing I can tell you is I am here - and imagine where I would ...

Tags: Exclusive: 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors,  Pfizer Latest News

AUG 29, 2014 - Zacks Investment Research

A Must Read - Share

Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog

Pfizer Inc. (PFE) announced that its vaccine candidate for clostridium difficile infection has been granted fast track designation by the FDA.

Tags: Pfizer's C. Difficile Vaccine Gets Fast Track Status - Analyst Blog,  Pfizer Latest News

AUG 29, 2014 - Zacks Investment Research

A Must Read - Share

Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog

Protalix (PLX) and Pfizer (PFE) announced that the FDA has approved Elelyso injection for pediatric patients suffering from type I Gaucher disease.

Tags: Protalix/Pfizer's Elelyso Approved in Pediatric Patients - Analyst Blog,  Pfizer Latest News

AUG 29, 2014 - TheStreet

A Must Read - Share

Why AstraZeneca (AZN) Stock Is Higher Today

NEW YORK (TheStreet) -- Shares of AstraZeneca PLCa are higher by 1.98% to $75.71 in mid-morning trading on Friday, as speculation stirs suggesting Pfizer Inc. might resume takeover discussions, the Wall Street Journal reports. The pharmaceutical company rejected the $120 billion bid Pfizer made back in May. Additionally, shares of AstraZeneca may be getting a boost after the company moved ...

Tags: Why AstraZeneca (AZN) Stock Is Higher Today,  Pfizer Latest News